Oops! Something went wrong, please try again later.
We are a commercial stage pharmaceutical company focused on developing and delivering innovative new treatments that help improve the lives of …See more
Does amryt’s delisting from the aim market affect my contingent value rights?
A:
No – CVR’s were granted to those who held ordinary shares in Amryt at September 20, 2019 and are a standalone instrument, Amryt’s AIM delisting does...
Save
Share
More
